Siqi Wang
300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Novel (Z)-3-(2-(quinazolin-4-yloxy)phenyl)acrylates as potential EGFR inhibitors deriving from the renovation of coumarin skeletons: Design, synthesis, characterization and antineoplastic activity.
Journal: Bioorganic & medicinal chemistry
Published: March 10, 2026
The degradation of maternal RNA-binding protein 4E-T regulates translational activation to ensure maternal-to-zygotic transition in mouse embryos.
Journal: Cellular and molecular life sciences : CMLS
Published: January 12, 2026
Nascent transcriptome of embryonic genome activation reveals a regulatory axis linking transcriptional priming to early lineage specification in mouse embryos.
Journal: Nucleic acids research
Published: September 09, 2025
Predicting relative efficacy of anthracyclines and taxanes in breast cancer neoadjuvant AC-T chemotherapy using longitudinal MRI radiomic model.
Journal: Frontiers in oncology
Published: December 13, 2024
Long-term effects of linear versus macrocyclic GBCAs on gene expression in the central nervous system of mice.
Journal: European radiology experimental
Published: August 02, 2024
Design, synthesis and antitumor activity of novel 4-oxobutanamide derivatives.
Journal: Bioorganic & medicinal chemistry letters
Published: August 01, 2024
The role of SRPK1-mediated phosphorylation of SR proteins in the chromatin configuration transition of mouse germinal vesicle oocytes.
Journal: Journal of biomedical research
Published: May 29, 2024
Identification of SMC2 and SMC4 as prognostic markers in breast cancer through bioinformatics analysis.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: February 02, 2024
Double-layer hollow mesoporous silica nanoparticles for ultrasound-guided photodynamic treatment.
Journal: Biomedical materials (Bristol, England)
Published: November 21, 2023
Inetetamab combined with pyrotinib and oral vinorelbine for patients with human epidermal growth factor receptor 2 positive advanced breast cancer: A single-arm phase 2 clinical trial.
Journal: Cancer pathogenesis and therapy
Published: May 30, 2023
Last Updated: 09/26/2026